What is Park Medi World Ltd revenue growth outlook?

Park Medi World Ltd operates in the Healthcare Services sector and has a current market cap of ₹9,477 Cr and P/E ratio of 34.12. For detailed revenue growth insights derived from the latest earnings call, visit the Park Medi World Ltd analysis page on Arthneeti AI.

What is Park Medi World Ltd current stock price?

Park Medi World Ltd current market price is ₹219.7. The stock trades at a P/E ratio of 34.12 with a market capitalisation of ₹9,477 Cr.

How does Arthneeti AI analyse Park Medi World Ltd?

Arthneeti AI uses natural language processing to analyse Park Medi World Ltd's earnings call transcripts and extract key insights on revenue growth, margins, capex plans, and fundraising activity. The analysis covers management commentary, forward guidance, and competitive positioning within the Healthcare Services sector.

Park Medi World Q1 FY27 Share Price & Earnings Call Analysis

₹219.70-0.70% today

Market cap: ₹9,477 Cr
P/E: 34.12
ROE: 16.79%
PEG: 6.47
Price to sales: 5.40
Debt to equity: 0.18
52W high / low: ₹299 / ₹144
Sales growth (5Y): 17.00%
EBITDA margin: 26.51%
Net profit margin: 16.29%
Promoter holding: 82.90%
Sales (last year): ₹1,756 Cr

All 12 ratios ↓

Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)

Guidance scorecard · Q1 FY27 call

What Park Medi World Ltd's management guided
and where it ranks in Healthcare Services

#12of 33 in
Healthcare Services

Revenue20–40%MarginsFlat CapexPlanned FundraisingPlanned Order bookWhat management said

RevenueQ1 FY27 call

20–40%

Park Medi World expects a revenue growth of 24% for FY’27, targeting Rs. 2,080 crores in revenue.
EBITDA is projected to grow by 25%, reaching Rs. 530 crores, and PAT is expected to grow by 32% to Rs. 360 crores.
ARPOB (Average Revenue Per Occupied Bed) growth guidance is 10%-12% annually for the next two years, driven by a shift toward advanced super-specialty treatments and inflation.
Bed capacity is planned to reach 4,740 by end of FY’27 and 5,740 by end of FY’28, with ongoing ramp-up in new facilities like Rudrapur and Panchkula.

2 more points from Park Medi World Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

Mature hospitals are expected to grow revenue steadily at 18-20%
Incremental economics remain attractive with return on capital currently at ~18%, and expected to improve by 150-200 bps over 12-18 months
New acquisitions like Rudrapur expected to ramp up revenues from Rs. 55-56 crores to Rs. 100 crores in first year with healthy EBITDA and PAT margins
ARPOB (Average Revenue per Occupied Bed) growth guided at 10-12% supported by shifting case mix towards high-end tertiary and quaternary care

2 more points from Park Medi World Ltd's call on margins

Create a free account to keep reading this call

See what Park Medi World Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned

Ongoing CAPEX and acquisition spend primarily focused on Rudrapur acquisition, Narela commissioning, and equipment upgrades across the network.
CAPEX per bed remains low at Rs.37 lakhs, the lowest among listed healthcare peers.
Total planned CAPEX for FY’27 and FY’28 is Rs.767 crores to add 2,130 beds, maintaining a blended CAPEX per bed of Rs.36 lakhs (includes acquisitions).
Additional CAPEX on Rudrapur expected to be around Rs.10-12 crores for equipment replacement and additions.
Adding 450 beds in Q3 FY’27, including 100 beds at Palam Vihar and 150 beds in Zirakpur.
Plan to increase total bed capacity to 4,740 by end FY’27 and to 5,740 by end FY’28.

2 more points from Park Medi World Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

Planned

Park Medi World Limited is currently fully funded for its stated growth plan to reach 5,740 beds by March 2028 through internal accruals and IPO proceeds.
The company has indicated no need for material fresh debt for its expansion and acquisitions.
Regarding promoter equity, there is a regulatory mandate to reduce promoter holding to 75% by December 2028.

2 more points from Park Medi World Ltd's call on fundraising

Create a free account to keep reading this call

See what Park Medi World Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Ask what Park Medi World Ltd said on the order book →

Full Q1 FY27 analysis

Full Healthcare Services ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

See all potential multibaggers Where does Park Medi World Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

1. Pick 3–15 stocks
2. Choose large, mid or small cap and your sectors
3. Get a portfolio built from the rankings

Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#	Company	Revenue guided	Margin guided	Market cap	P/E
1		40%+	Up 2%+	₹903 Cr	—
2		40%+	Flat	₹583 Cr	22.2
3	Aster DM Quality Care Ltd	20–40%	Up 2%+	₹58,782 Cr	162.9
4		20–40%	Up 0–2%	₹1,730 Cr	17.5
5		20–40%	Up 0–2%	₹580 Cr	11.9
6		20–40%	Flat	₹1.13L Cr	53.9

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of Park Medi World Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.